Centchroman(CAS: 31477-60-8)

Centchroman (CAS: 31477-60-8) is regulated under various guidelines. It is classified under the Globally Harmonized System of Classification and Labelling of Chemicals (GHS) as a Category 2 teratogen. In the European Union, it is covered by the Registration, Evaluation, Authorization and Restriction of Chemicals (REACH) regulation. It is also subject to requirements by the U.S. Environmental Protection Agency (EPA) and the Food and Drug Administration (FDA), particularly in agricultural applications and pharmaceuticals.

Several alternatives to Centchroman (CAS: 31477-60-8) exist in synthesis. Common alternatives include acarbose and miglitol, which are used as antidiabetic agents. Other reagents such as sitagliptin can also be used as substitutes. These alternatives offer similar or improved efficacy with different mechanisms of action, making them viable options in the synthesis of similar compounds.

The market for Centchroman (CAS: 31477-60-8) is primarily driven by its use as a male contraceptive. Recent research trends focus on understanding its mechanism of action and developing more effective and safer alternatives. The market is slowly declining due to the availability of newer, more effective contraceptives. However, there is ongoing interest in its potential in other therapeutic areas such as cancer and diabetes.

Waste containing Centchroman (CAS: 31477-60-8) should be handled carefully to ensure safety and compliance with environmental regulations. Waste should be collected in appropriate containers and stored separately. Professional waste disposal services should be used for incineration or other methods of disposal. Environmental precautions include ensuring that no waste is released into the environment and that proper personal protective equipment is worn during handling. Compliance with local and national hazardous waste regulations is essential.